A human retinal pigment epithelial cell model used to study inducible gene expression, cell cycle regulation, and functional genomics. Available exclusively from CancerTools. Save 30% on this cell line this autumn. Use code ACA26CELL at checkout.
| Inventor | Institute |
|---|---|
| Jonathon Pines | University of Cambridge |
| SKU: | 153242 |
|---|---|
| Product description: | RPE1 FRT/TR is an engineered RPE1 cell line generated by random integration of an FRT site and Tet repressor gene. Designed for use with the Flp-In™ system, it enables the generation of cell lines with tetracycline-inducible expression of genes of interest, providing a convenient platform for controlled gene expression studies. The line has been used to generate inducible cell models expressing APC15-IRES2-mRuby, APC15-3xFLAG and Cyclin B1-L45A-HA using a modified pcDNA5/FRT/TO vector. |
| Conditional: | Yes |
| Conditional description: | Tetracycline-inducible expression of genes of interest. |
| Production details: | This tetracycline-inducible RPE1 cell line was created by random integration of an FRT site and a Tet repressor gene into retinal pigment epithelial 1 (RPE1) cells. |
| Additional notes: | Selection markers: This cell line is resistant to Zeocin (FRT cassette) and Blasticidin (Tet repressor cassette). Resistance to Hygromycin and Puromycin is inherited from the parental RPE1 cell line. Flp-In™ integration: The originating laboratory replaced the hygromycin resistance cassette in the pcDNA5/FRT/TO vector with a neomycin resistance marker and used Geneticin (G418 analogue) for selection of successfully integrated clones. Culture recommendations: Use tetracycline-free serum when generating inducible cell lines to minimise background expression from tetracycline-responsive constructs. |
| Parental cell line: | RPE1 |
| Cat. #: | 153242 |
|---|---|
| Provenance and Ownership: | The RPE1 FRT/TR Cell Line is owned by Cancer Research UK. CancerTools supplies the RPE1 FRT/TR Cell Line under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing RPE1 FRT/TR Cell Line directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements. |
| Unit size: | 1×10^6 cells / vial |
| Research Fields: | Genetics |
| Organism: | Human |
| Tissue: | Eye |
| Growth properties: | Adherent cell line |
| Initial handling information: | Thaw cells rapidly and transfer into pre-warmed F12:DMEM (1:1) medium supplemented with 10% FCS. Allow cells to recover and establish normal growth before commencing transfection or Flp-In™ integration experiments. |
|---|---|
| Format: | Frozen |
| Storage conditions: | Liquid Nitrogen |
| Shipping conditions: | Dry ice |
| Growth medium: | F12:DMEM (1:1) media supplemented with 10% FCS. |
| Mycoplasma free: | Yes |
| Biosafety level: | 1 |
| References: |
Mansfield et al. 2011. Nat Cell Biol. 13:1234-43. PMID: 21926987 |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.